Quest Diagnostics Inc Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax
Quest Diagnostics Inc (DGX) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax of -$1.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax · last filed 2026-02-26
- Quest Diagnostics Inc other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax for the quarter ending 2025-12-31 was -$1.00M.
- Quest Diagnostics Inc other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Quest Diagnostics Inc other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax for the quarter ending 2024-12-31 was -$1.00M, a 150.00% decline year-over-year.
- Quest Diagnostics Inc other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax for the quarter ending 2024-09-30 was $3.00M.
- Quest Diagnostics Inc other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax for fiscal 2025 was -$1.00M, a 150.00% decline from fiscal 2024.
- Quest Diagnostics Inc other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax for fiscal 2024 was $2.00M, a 0.00% change from fiscal 2023.
- Quest Diagnostics Inc other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax for fiscal 2023 was $2.00M, a 100.00% increase from fiscal 2022.
- Quest Diagnostics Inc other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax for fiscal 2022 was $1.00M, a 0.00% change from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.00M derived: sum of 2 quarters · filed 2026-02-26 | -$1.00M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-10-21 | $0.00 10-Q · filed 2025-10-21 | ||
| 2024-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.00M derived: sum of 2 quarters · filed 2026-02-26 | $2.00M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $3.00M 10-Q · filed 2025-10-21 | $3.00M 10-Q · filed 2025-10-21 | ||
| 2023-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.00M derived: sum of 2 quarters · filed 2026-02-26 | $2.00M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-10-23 | $0.00 10-Q · filed 2024-10-23 | ||
| 2022-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $1.00M derived: sum of 2 quarters · filed 2025-02-20 | $1.00M 10-K · filed 2025-02-20 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-10-21 | $0.00 10-Q · filed 2022-10-21 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $1.00M derived: sum of 2 quarters · filed 2024-02-22 | $1.00M 10-K · filed 2024-02-22 | |
| 2021-09-30 | $1.00M 10-Q · filed 2022-10-21 | $1.00M 10-Q · filed 2022-10-21 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $3.00M derived: sum of 2 quarters · filed 2023-02-21 | $3.00M 10-K · filed 2023-02-21 | |
| 2020-09-30 | $3.00M 10-Q · filed 2021-10-22 | $3.00M 10-Q · filed 2021-10-22 | ||
| 2019-12-31 | $5.00M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |